190 related articles for article (PubMed ID: 36201590)
1. A noncoding single-nucleotide polymorphism at 8q24 drives
Yanchus C; Drucker KL; Kollmeyer TM; Tsai R; Winick-Ng W; Liang M; Malik A; Pawling J; De Lorenzo SB; Ali A; Decker PA; Kosel ML; Panda A; Al-Zahrani KN; Jiang L; Browning JWL; Lowden C; Geuenich M; Hernandez JJ; Gosio JT; Ahmed M; Loganathan SK; Berman J; Trcka D; Michealraj KA; Fortin J; Carson B; Hollingsworth EW; Jacinto S; Mazrooei P; Zhou L; Elia A; Lupien M; He HH; Murphy DJ; Wang L; Abyzov A; Dennis JW; Maass PG; Campbell K; Wilson MD; Lachance DH; Wrensch M; Wiencke J; Mak T; Pennacchio LA; Dickel DE; Visel A; Wrana J; Taylor MD; Zadeh G; Dirks P; Eckel-Passow JE; Attisano L; Pombo A; Ida CM; Kvon EZ; Jenkins RB; Schramek D
Science; 2022 Oct; 378(6615):68-78. PubMed ID: 36201590
[TBL] [Abstract][Full Text] [Related]
2. Inherited variant on chromosome 11q23 increases susceptibility to IDH-mutated but not IDH-normal gliomas regardless of grade or histology.
Rice T; Zheng S; Decker PA; Walsh KM; Bracci P; Xiao Y; McCoy LS; Smirnov I; Patoka JS; Hansen HM; Hsuang G; Wiemels JL; Tihan T; Pico AR; Prados MD; Chang SM; Berger MS; Caron A; Fink S; Kollmeyer T; Rynearson A; Voss J; Kosel ML; Fridley BL; Lachance DH; Eckel-Passow JE; Sicotte H; O'Neill BP; Giannini C; Wiencke JK; Jenkins RB; Wrensch MR
Neuro Oncol; 2013 May; 15(5):535-41. PubMed ID: 23361564
[TBL] [Abstract][Full Text] [Related]
3. The contribution of the rs55705857 G allele to familial cancer risk as estimated in the Utah population database.
Hummel S; Kohlmann W; Kollmeyer TM; Jenkins R; Sonnen J; Palmer CA; Colman H; Abbott D; Cannon-Albright L; Cohen AL
BMC Cancer; 2019 Mar; 19(1):190. PubMed ID: 30823903
[TBL] [Abstract][Full Text] [Related]
4. IDH-mutant glioma specific association of rs55705857 located at 8q24.21 involves MYC deregulation.
Oktay Y; Ülgen E; Can Ö; Akyerli CB; Yüksel Ş; Erdemgil Y; Durası IM; Henegariu OI; Nanni EP; Selevsek N; Grossmann J; Erson-Omay EZ; Bai H; Gupta M; Lee W; Turcan Ş; Özpınar A; Huse JT; Sav MA; Flanagan A; Günel M; Sezerman OU; Yakıcıer MC; Pamir MN; Özduman K
Sci Rep; 2016 Jun; 6():27569. PubMed ID: 27282637
[TBL] [Abstract][Full Text] [Related]
5. Gene Expression Profiling Stratifies IDH1-Mutant Glioma with Distinct Prognoses.
Cheng W; Ren X; Zhang C; Cai J; Han S; Wu A
Mol Neurobiol; 2017 Oct; 54(8):5996-6005. PubMed ID: 27696222
[TBL] [Abstract][Full Text] [Related]
6. Isocitrate dehydrogenase 1 mutation enhances 24(S)-hydroxycholesterol production and alters cholesterol homeostasis in glioma.
Yang R; Zhao Y; Gu Y; Yang Y; Gao X; Yuan Y; Xiao L; Zhang J; Sun C; Yang H; Qin J; Li J; Zhang F; Zhang L; Ye J
Oncogene; 2020 Oct; 39(40):6340-6353. PubMed ID: 32855525
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of IDH-mutant gliomas with non-canonical IDH mutation.
Poetsch L; Bronnimann C; Loiseau H; Frénel JS; Siegfried A; Seizeur R; Gauchotte G; Cappellen D; Carpentier C; Figarella-Branger D; Eimer S; Meyronet D; Ducray F;
J Neurooncol; 2021 Jan; 151(2):279-286. PubMed ID: 33205355
[TBL] [Abstract][Full Text] [Related]
8. Diffuse gliomas classified by 1p/19q co-deletion, TERT promoter and IDH mutation status are associated with specific genetic risk loci.
Labreche K; Kinnersley B; Berzero G; Di Stefano AL; Rahimian A; Detrait I; Marie Y; Grenier-Boley B; Hoang-Xuan K; Delattre JY; Idbaih A; Houlston RS; Sanson M
Acta Neuropathol; 2018 May; 135(5):743-755. PubMed ID: 29460007
[TBL] [Abstract][Full Text] [Related]
9. Lack of B and T cell reactivity towards IDH1
Weenink B; van Brakel M; Wijers R; Sillevis Smitt PAE; French PJ; Debets R
J Neurooncol; 2019 Aug; 144(1):79-87. PubMed ID: 31240524
[TBL] [Abstract][Full Text] [Related]
10. Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma.
Raghunathan A; Olar A; Vogel H; Parker JR; Coventry SC; Debski R; Albarracin CT; Aldape KD; Cahill DP; Powell SZ; Fuller GN
Ann Diagn Pathol; 2012 Aug; 16(4):255-9. PubMed ID: 22445362
[TBL] [Abstract][Full Text] [Related]
11. Isocitrate Dehydrogenase Mutations are Better Prognostic Marker than O6-methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastomas - a Retrospective, Single-centre Molecular Genetics Study of Gliomas.
Houdova Megova M; Drábek J; Dwight Z; Trojanec R; Koudeláková V; Vrbková J; Kalita O; Mlcochova S; Rabcanova M; Hajdúch M
Klin Onkol; 2017; 30(5):361-371. PubMed ID: 29031038
[TBL] [Abstract][Full Text] [Related]
12. Monoallelic IDH1 R132H Mutation Mediates Glioma Cell Response to Anticancer Therapies via Induction of Senescence.
Zhan D; Ma D; Wei S; Lal B; Fu Y; Eberhart C; Laterra J; Ying M; Li Y; Meeker A; Lopez-Bertoni H; Xia S
Mol Cancer Res; 2021 Nov; 19(11):1878-1888. PubMed ID: 34348994
[TBL] [Abstract][Full Text] [Related]
13. IDH1 mutation predicts seizure occurrence and prognosis in lower-grade glioma adults.
Tang T; Wang Y; Dai Y; Liu Q; Fan X; Cheng Y; Tang J; Xiao X; Shan Y; Wei P; Zhao G
Pathol Res Pract; 2024 Feb; 254():155165. PubMed ID: 38286053
[TBL] [Abstract][Full Text] [Related]
14. Adaptive Evolution of the GDH2 Allosteric Domain Promotes Gliomagenesis by Resolving IDH1
Waitkus MS; Pirozzi CJ; Moure CJ; Diplas BH; Hansen LJ; Carpenter AB; Yang R; Wang Z; Ingram BO; Karoly ED; Mohney RP; Spasojevic I; McLendon RE; Friedman HS; He Y; Bigner DD; Yan H
Cancer Res; 2018 Jan; 78(1):36-50. PubMed ID: 29097607
[TBL] [Abstract][Full Text] [Related]
15. Identification of a Prognostic Hypoxia-Associated Gene Set in IDH-Mutant Glioma.
Dao Trong P; Rösch S; Mairbäurl H; Pusch S; Unterberg A; Herold-Mende C; Warta R
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30257451
[TBL] [Abstract][Full Text] [Related]
16. IDH1/2 mutation is associated with seizure as an initial symptom in low-grade glioma: A report of 311 Chinese adult glioma patients.
Zhong Z; Wang Z; Wang Y; You G; Jiang T
Epilepsy Res; 2015 Jan; 109():100-5. PubMed ID: 25524848
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of the TWEAK receptor Fn14 in IDH1 wild-type and mutant gliomas.
Hersh DS; Peng S; Dancy JG; Galisteo R; Eschbacher JM; Castellani RJ; Heath JE; Legesse T; Kim AJ; Woodworth GF; Tran NL; Winkles JA
J Neurooncol; 2018 Jun; 138(2):241-250. PubMed ID: 29453678
[TBL] [Abstract][Full Text] [Related]
18. An in vivo patient-derived model of endogenous IDH1-mutant glioma.
Luchman HA; Stechishin OD; Dang NH; Blough MD; Chesnelong C; Kelly JJ; Nguyen SA; Chan JA; Weljie AM; Cairncross JG; Weiss S
Neuro Oncol; 2012 Feb; 14(2):184-91. PubMed ID: 22166263
[TBL] [Abstract][Full Text] [Related]
19. Combined IDH1 mutation and MGMT methylation status on long-term survival of patients with cerebral low-grade glioma.
Tanaka K; Sasayama T; Mizukawa K; Takata K; Sulaiman NS; Nishihara M; Kohta M; Sasaki R; Hirose T; Itoh T; Kohmura E
Clin Neurol Neurosurg; 2015 Nov; 138():37-44. PubMed ID: 26276726
[TBL] [Abstract][Full Text] [Related]
20. Association of
Murnyak B; Huang LE
Cells; 2021 Aug; 10(8):. PubMed ID: 34440884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]